To test this hypothesis, we set up a system in which we used OVA protein expressed by the tumor cells as a molecular model for TAA and an OVA-specific CD8+ T cell hybridoma cell line B3Z to examine the effect of IFNγ and viral infection on the direct presentation of TAA to T cells by the tumor cells. The gene discussed is CD8A; the disease is neoplasm.